Cancer in dogs is detected through a combination of physical examination, imaging, lab work, and tissue sampling. There’s no single test that catches every type, so veterinarians typically start with what they can see and feel, then work inward using progressively more detailed tools. For owners, detection often begins at home: noticing a lump that wasn’t there before, unexplained weight loss, or a change in energy level that doesn’t bounce back.
Warning Signs You Can Spot at Home
The most reliable early detection tool is your own hands. Regularly petting and running your fingers over your dog’s body is the best way to find lumps, bumps, or swellings that persist or keep growing. Not every lump is cancerous, but any new mass that doesn’t resolve within a couple of weeks deserves a vet visit.
Beyond lumps, there are several changes worth paying attention to:
- Unexplained weight loss in a dog that isn’t on a diet
- Loss of appetite lasting more than a day or two
- Sores that won’t heal, which can signal skin cancer or infection
- Unusual bleeding or discharge from any part of the body, including vomiting or diarrhea
- Offensive odor from the mouth, ears, or skin
- Difficulty eating or swallowing, often linked to cancers of the mouth or throat
- Reluctance to exercise or a noticeable drop in stamina
- Persistent limping, which can indicate bone cancer rather than a simple sprain
- Difficulty breathing, urinating, or defecating
None of these signs automatically mean cancer. Many have benign explanations. But when they persist, especially in combination, they warrant diagnostic follow-up.
Physical Exam and Initial Workup
A veterinarian’s first step is a thorough physical examination, checking lymph nodes for swelling, palpating the abdomen for internal masses, and examining the mouth, skin, and joints. Routine blood work, including a complete blood count and chemistry panel, can reveal abnormalities like elevated white blood cells, anemia, or organ dysfunction that hint at an underlying problem. These tests don’t diagnose cancer on their own, but they help the vet decide what to investigate next.
Blood-Based Cancer Screening
Newer blood tests go beyond standard panels to look for markers more closely tied to cancer. Two biomarkers in particular, thymidine kinase (TK1) and C-reactive protein (CRP), have shown promise. TK1 rises when cells are dividing rapidly, which happens in cancer. CRP is a general inflammation marker that correlates with disease severity. Neither is cancer-specific on its own, but when evaluated together using a combined scoring algorithm, they perform significantly better at identifying dogs with hidden, early-stage cancer.
A more recent approach involves liquid biopsy tests that measure fragments of tumor DNA circulating in the bloodstream. One such test showed strong accuracy for blood cancers like lymphoma and leukemia (95% accuracy by one measure) and moderate accuracy for solid tumors like carcinomas (75%) and sarcomas (76%). At a threshold designed to separate healthy dogs from those with tumors, the test correctly identified cancer in 82% of affected dogs while correctly clearing 73% of healthy ones. These tests are still relatively new and work best as screening tools rather than definitive diagnoses.
Imaging: X-Rays, Ultrasound, CT, and MRI
When a vet suspects cancer or needs to see what’s happening inside, imaging is the next step. The choice of tool depends on where the suspected tumor is and what type of tissue is involved.
X-rays (radiographs) are the most accessible option and are particularly useful for evaluating bone abnormalities, scanning for internal masses, and checking whether cancer has spread to the lungs. They’re often the first imaging test ordered. Ultrasound is the go-to for examining the abdominal cavity. It shows the size, shape, and internal structure of organs and tumors in real time, and it can guide a needle directly into a mass for sampling.
CT scans provide more anatomical detail than standard X-rays and are preferred for complex areas like the skull, nasal passages, brain, and lungs. They’re especially valuable for surgical planning, giving the vet a precise picture of a tumor’s size and position. MRI excels at imaging soft tissue, particularly the brain and spinal cord, making it the best choice when neurological symptoms suggest a tumor in the central nervous system. Both CT and MRI typically require general anesthesia because the dog needs to stay completely still during the scan.
Fine Needle Aspirate vs. Tissue Biopsy
Finding a mass is one thing. Figuring out what it is requires getting a sample of its cells. The two main approaches are fine needle aspiration and surgical biopsy, and they serve different purposes.
A fine needle aspirate (FNA) uses a thin needle and syringe to pull a small cluster of cells from a lump. It’s quick, minimally invasive, and often doesn’t require sedation. It’s excellent for determining whether a mass is cancerous in the first place. In one study of brain tumors, FNA correctly identified all masses as cancerous. The limitation is precision: it identified the specific tumor type only about 50% of the time, because it collects individual cells rather than a chunk of tissue with its architecture intact.
A core tissue biopsy, taken with a larger needle or through surgery, removes a small cylinder or wedge of tissue. This preserves the structure of the mass, which a pathologist needs to classify the exact cancer type and grade. In the same study, core biopsies matched the final diagnosis 90% of the time. The trade-off is that biopsies are more invasive and usually require sedation or anesthesia.
In practice, most vets start with an FNA. If it confirms cancer or the results are inconclusive, a biopsy follows to pin down the diagnosis and guide treatment decisions.
Specialized Testing for Lymphoma
Lymphoma is one of the most common cancers in dogs, and confirming it often requires more than a standard biopsy. A technique called flow cytometry analyzes cells from a lymph node sample by passing them through a laser, one at a time, to identify what type of immune cell has become cancerous. This matters because the two main types of lymphoma, B-cell and T-cell, respond differently to treatment and carry different prognoses. B-cell lymphoma generally has a better outlook.
Flow cytometry identifies these cell types by detecting specific surface proteins on the cancerous cells. In a healthy lymph node, you’d see a diverse mix of cell types. In lymphoma, there’s a telltale pattern: a single population of identical cells expanding out of control. When the diagnosis is still uncertain, a molecular test called PARR can detect genetic rearrangements unique to cancerous immune cells, helping distinguish lymphoma from benign lymph node swelling, which can otherwise look very similar under a microscope.
When to Start Screening
The right age to begin cancer screening depends heavily on your dog’s breed and size. A study of over 3,000 dogs found that large and giant breeds are diagnosed at much younger ages. Mastiffs had a median diagnosis age of just 5 years. Saint Bernards, Great Danes, and Bulldogs were typically diagnosed around age 6. Boxers followed at 6.2 years, while Bernese Mountain Dogs and Vizslas averaged 7 years.
Because cancer develops over a long preclinical period before symptoms appear, researchers recommend starting annual screening about two years before the typical diagnosis age for your dog’s breed or weight class. That translates to age 7 for most dogs, but as early as age 3 or 4 for high-risk giant breeds. Certain breeds, including Bulldogs, Boxers, Vizslas, French Bulldogs, and Boston Terriers, develop cancer significantly earlier than their body weight alone would predict, so breed-specific guidelines are more reliable than weight-based estimates for these dogs.
Annual screening at the appropriate age gives the best chance of catching cancer before it progresses, when treatment options are broader and outcomes tend to be better.